XIAP and ovarian cancer: β-Elemene not only reduced the XIAP protein level (Fig. 4) but also abrogated cisplatin-induced XIAP expression in resistant ovarian tumor cells (Fig. 5), indicating the involvement of XIAP in the mechanism of β-elemene action in resistant ovarian cancer cells.